Potential role of flavonoids in the prevention of intestinal neoplasia
A review of their mode of action and their clinical perspectives
Cite this article as: Hoensch, H.P. & Kirch, W. Int J Gastrointest Canc (2005) 35: 187. doi:10.1385/IJGC:35:3:187 Abstract
Intestinal neoplasia (adenomas and carcinomas) can possibly be prevented by a diet rich in vegetables and fruits, treatment with aspirin and other nonsteroidal antiinflammatory drugs, and early colonoscopic removal of adenomas. Ballast, fiber, and secondary plant products could play a major role in colon cancer prevention. Recently there has been much experimental work in vitro and in vivo about flavonoids as inducers of bioprevention. Flavonoids are secondary plant products with a wide variety of beneficial biological properties, and they possess anticarcinogenic, antimutagenic, and antioxidative modes of actions. Flavonoids are the main components of a healthy diet containing fruits and vegetables and are concentrated especially in tea, apples, and onions. We will focus this review on flavonoids which are derived from tea products such as proanthocyanidins (green tea) and flavons (camomille tea). Oral supplementation with bioflavonoids derived from tea could be used in humans to prevent growth of intestinal neoplasia such as adenomatous polyps of the colon. Flavonoids are a large group of natural compounds of which only a few have been used in animal models, cell cultures, and enzyme studies to inhibit mutagenic and carcinogenic events. Their clinical mode of action was evaluated by epidemiological studies, but no intervention studies in humans have been performed so far. In vitro flavonoids can bind electrophils, inactivate oxygen radicals, prevent lipid peroxidation, and inhibit DNA oxidation. In cell cultures they increase the rate of apoptosis, inhibit cell proliferation, and angiogenesis. In vivo they can induce the activities of protective enzymes (conjugating enzymes such as glutathione transferases and glucuronosyl transferases) of the intestine and the liver. In models of intestinal polyposis, flavonoids suppress polyp formation. Some epidemiological studies show a protective effect of flavonoids contained in fruits, vegetables, and tea.Flavonoid mixtures of tea origin supplied as nutritional supplements could be studied as a new way of bioprevention of intestinal neoplasia (colon adenomas and cancer). Therefore, a controlled, randomized clinical study should be performed to evaluate the efficacy of flavonoids.
Key Words Flavonoids intestinal neoplasia nonsteroidal antiinflammatory drugs References
Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and metaanalysis.
Johnson IT. New approaches to the role of diet in the prevention of cancers of the alimentary tract.
Ferguson LR, Philpott M, Karunasinghe N. Dietary cancer and prevention using antimutagens.
Aherne SA, O’Brien NM. Dietary flavonols: chemistry, food content, and metabolism.
Roos JA, Kasum CM. Dietary flavonoids: bioavialability, metabolic effects and safety.
Ann Rev Nutr
Yang CS, Malaikal P, Meng X. Inhibition of carcinogenesis by tea.
Annu Rev Pharmacol Toxicol 2002;33:237–253.
World Cancer Research Fund.
Food, Nutrition and the Prevention of Cancer: A Global Perspective. Menasha, WI: Banta Book Group, 1997.
Pufulete M, Al-Ghnaniem R, Leather AJM, et al. Folate status, genomic DNA hypomethylation and risk of colorectal adenoma and cancer: a case control study.
Baron J A, Cole B F, Sandler R S, et al. A randomized trial of aspirin to prevent colorectal adenomas.
N Engl J Med
Benamouzig R, Deyra J, Martin A, et al. Daily soluble aspririn and prevention of colorectal adenome recurrence: one year results of the APACC trial.
Rahme E, Barkun AN, Toubout Y, et al. The cyclooxygenase 2-inhibitors Rofecoxib and Celecoxib prevent colorectal neoplasia occurence.
Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
N Engl J Med
Knekt P, Jarvinen R, Seppanen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms.
Am J Epidem 1997;146:223–230.
Yang CS, Landau JM, Huang MT, et al. Inhibition of carcinogenesis by dietary polyphenolic compounds.
Annu Rev Nutri
Paradi DS, Loftus EV, Kremers WK, et al. Ursodesoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
Burt RW. Colon cancer screening.
Liebermann DA, Weiss DG, Bond JH. Use of colonoscopy to screen asymptomatic adults for colorectal cancer.
N Engl J Med
Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high fiber cereal supplement on the recurrence of colorectal adenomas.
N Engl J Med
Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low fat, high fiber diet on the recurrence of colorectal adenomas.
N Engl J Med
Lacy AM, Garcia-Valdecasas JC, Delgado S. Laparoscopy assisted colectomy versus open colectomy for treatment of nonmetastatic colon cancer: a randomised trial.
Galati G, Moridani MY, Chan TS, O’Brian PJ. Cancer chemoprevention and apoptotis mechanisms induced by dietary polyphenolics.
Drug Metab Drug Interact 2000;17:311–349.
Manthey JA, Grohmann K, Gutherie N. Biological properties of citrus flavonoids pertaining to cancer and inflammation.
Curr Med Chem
Greenberg RE, Baron JA, Tosteson TD. A clinical trial of antioxidant vitamins to prevent colorectal adenoma.
N Engl J Med
Kent TJ, Allen NE, Spencer EA, et al. The effect of diet on risk of cancer.
Suleiman S, Rex OK, Sonnenberg A. Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis.
Bertram B, Bartsch H. Krebsprävention durch grünen Tee: Wirklichkeit und Wunschdenken.
Wien Med Wochenschr
Kuo SM. Dietary flavonoids and cancer prevention: evidence and potential mechanism.
Crit Rev Oncol 1997;8:47–69.
Witte JS, Longnecker MP, Bird CL, Lee ER, Frankl HD, Haile RW. Relation of vegetable, fruit and grain consumption to colorectal adenomatous polyps.
Am J Epidem 1996;144:1015–1027.
Setiawan VW, Chang F, Yu GP. Protective effect of green tea on the risks of chronic gastritis and stomach cancer.
Int J Cancer
Dorant E, van den Brandt PA, Goldbohm RA, Sturmans F. Consumption of onoins and a reduced risk of stomach carcinoma.
Arts IC, Jacobs DR Jr, Gross M, Harnack LJ, Folsom AR. Dietary catechins and cancer incidence among postmenopausal women: the Iowa women’s health study.
Cancer Causes Control
Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary flavonoids and cancer risk in the Zuitphen Elderly Study.
Goldbohm RA, et al. Flavonoid intake and risk of cancer: a prospective cohort study.
Am J Epidem Suppl 1995;141:61S.
Michels KB, Edward G, Joshipura KJ, et al. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers.
J Natl Cancer Inst
US Preventive Service Task Force. Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommodations and rationale.
Ann Int Med 2003;139:51–70.
Riboli E, Norat T. Epidemiological evidence of the protective effect of fruit and vegetables on cancer risk.
Am J Clin Nutr 2003;78:559–569.
Goodlad R, Englyst HN. Redefining dietary fibre: potentially a recipe for disaster.
Peters U, Sinha R, Chatterjee N, et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme.
Bingham SA, Day NE, Luben R, et al. Dietary fiber in food and protection against colorectal cancer in the European Protective Investigation into Cancer and Nutrition: an observational study.
Hoensch H, Morgenstern I, Petereit G, et al. Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system.
Hoensch HP, Steinhardt HJ, Weiss H, et al. Effects of semisynthetic diets on the xenobiotic metabolizing enzyme activity and on morphology of small intestinal mucosa in humans.
Steele VE, Kelloff GJ, Balentine D, et al. Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro assays.
Hara Y, Green tea, health benefits and applications, in
Food Science and Technology. New York-Basel: Marcel Dekker, 2001.
Raab B, Jacobasch G, Heinevetter L, Maurer S. Role of flavonols and anthocyanins from fruits and vegetables in cancer prevention, in
Phytochemicals and Phytopharmaceuticals. (Shahidi F, Ho C-T, eds.) Champaign, IL: AOCS Press, 2000, pp. 154–163.
Yamane T, Nakatani H, Kikuoka N, et al. Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis.
Nijhoff WA, Groen GM, Peters WHM. Induction of rat hepatic and intestinal glutathion S-transferases and glutathione by dietary naturally occuring anticarcinogens.
Int J Oncol 1993;1131–1139.
vander Logt EM, Roelofs HMJ, Nagengast FM, Peters WHM. Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens.
Salucci M, Stivala LA, Maiani G, et al. Flavonoid uptake and their effect on cell cycle of human colon adenocarcinoma cells.
Brit J Cancer
Duthie SJ, Dobson VL. Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro.
Eur J Nutr
Lautraite S, Musonda AC, Doehmer J, et al. Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP 1A2, CYP 1A1.
Kuntz S, Wenzel U, Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity and apoptosis in human cancer cell lines.
Eur J Nutr
Wenzel U, Kuntz S, Brendel MD, Daniel H. Dietary flavone is a potent inducer in human carcinoma cells.
Grady WM. Genetic testing for high risk colon cancer patients.
Skibola CF, Smith MT. Potential health impacts of excessive flavonoid intake.
Free Rad Biol Med
Hayes JD, McLellen LI. Glutathione and glutathionedependent enzymes represent a coordinately regulated defence against oxidative stress.
Free Rad Res
Evans RC, Fear S, Ashby D, et al. Diet and colorectal cancer:an investigation of the lectin / galactose hypothesis.
Slattery ML, Edwarts S, Curtin K, et al. Physical activity and colorectal cancer.
Am J Epidemiol
Radtke J, Linseisen J, Wolfram G. Fasting plasma concentrations of selected flavonoids as biomarkers of their ordinary dietary intake.
Eur J Nutr